Adjusted survival models for 1-year survival stratified per recipient diagnosis
| Hazard ratio (95% CI) | p-value | |
| Patient grouped according to SP-A2 variant 1A0 and 1A1 | ||
| Death | 2.9 (1.2–6.9) | 0.02 |
| Recipient age | 1.0 (1.0–1.1) | 0.04 |
| Female | 0.7 (0.27–1.8) | 0.4 |
| Bilateral lung transplant | 5.4 (1–27.5) | 0.04 |
| CMV mismatch | 0.8 (0.3–2.2) | 0.7 |
| Sex mismatch | 1.1 (0.4–2.9) | 0.8 |
| Patient grouped according to SP-A2 genotype 1A01A0 and 1A01A1 | ||
| Death | 11.3 (1.6–80.5) | 0.02 |
| Recipient age | 1.1 (1.0–1.2) | 0.1 |
| Female | 1.1 (0.3–4.5) | 0.9 |
| Bilateral lung transplant | 2.9 (0.5–15.8) | 0.2 |
| CMV mismatch | 0.4 (0.07–2.5) | 0.4 |
| Sex mismatch | 1.1 (0.2–6.2) | 0.9 |
SP: surfactant protein; CMV: cytomegalovirus.